novo nordisk's wegovy reduces cardiovascular risk more than lilly's tirzepatide Why weight-loss drug shows promise for heart disease Zepbound results in more weight

By targeting both, Tirzepatide offers a dual mechanism that enhances insulin response and supports sustainable weight loss

Semaglutide deep-dive Semaglutide is sold under three brand names, all manufactured by Novo Nordisk: Ozempic -- weekly injection, FDA-approved for type 2 diabetes (doses 0.25 mg, 0.5 mg, 1 mg, 2 mg) Wegovy -- weekly injection, FDA-approved for chronic weight management in 2021 (doses up to 2.4 mg) [3] Rybelsus -- daily oral tablet, approved for type 2 diabetes For weight loss specifically, Wegovy is the on-label choice

Check your dosage calculations to ensure accuracy at these lower doses, since small measurement errors have a larger proportional impact when the dose itself is small

What other services do online wellness platforms offer

This way, your medication can be safely monitored and administered